Does dose reduction of afatinib affect treatment outcomes of patients with EGFR-mutant metastatic non-small cell lung cancer in real-world clinical practice?
在真实临床实践中,降低阿法替尼剂量是否会影响 EGFR 突变转移性非小细胞肺癌患者的治疗结果?
期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-23-691
Poh, Mau Ern; Chai, Chee Shee; Liam, Chong Kin; Ho, Gwo Fuang; Pang, Yong Kek; Hasbullah, Harissa Husainy; Tho, Lye Mun; Muhamad Nor, Ibtisam; Ho, Kean Fatt; Thiagarajan, Muthukkumaran; Samsudin, Azlina; Omar, Azza; Ong, Choo Khoon; Soon, Sing Yang; Tan, Sin Nee; How, Soon Hin